Nvidia pauses for breath as investors await earnings

Chip firm warns customers that bottlenecks will take time to clear

Reaction suggests investors may no longer swayed by earnings ‘beats’

Tesla posted one its sharpest year-on-year declines in revenue, with boss Elon Musk warning that the trend is set to continue through what is expected to be one of the most challenging periods in the

Analysts have low-balled estimates, possibly to account for the impact of tariffs

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Wise had 9.8 million customers in the first quarter, up 17% year on year and 5% quarter-on-quarter